India surpassed 300,000 coronavirus deaths

India broke the barrier of 300,000 coronavirus deaths on Monday, registering more than 4,000 deaths per day, while infections continue on a downward trend, with just over 220,000 cases in the past 24 hours.

The country added 100,000 new deaths in less than a month, in a rapid increase after days like the last were recorded with more than 4,000 daily deaths, with a total of 4,454, bringing the global tally since the start of pandemic at 303,729, according to data from India’s Ministry of Health.

These figures contrast with the number of infections which fell to 222,315, far from the 400,000 reported daily at the peak of infections, and which brings the total to 26.7 million., a figure that only exceeds the United States, with just over 33 million.

Despite the significant reduction in infections, India remains embroiled in a second wave that left the country on the verge of collapse within weeks as a lack of basic supplies such as oxygen prompted authorities to seek help international.

In this direction, The western state of Maharashtra, the most affected by the pandemic, concentrates for the second day in a row more than 25% of the deaths recorded in the country, with more than 1,300 in a single day, while the positives are less than 30,000.

Estos datos distan de Nueva Delhi, una ciudad de más de 20 million inhabitants que en esta última jornada registró 189 fallecidos y 1.649 contagios, a number of infections that no se veían desde finales de marzo, cuando lo peor de la pandemia estaba aún por arrive.

The capital has extended its sixth week of total containment, although it is considering the possibility of launching a de-escalation process in the coming days., the regional government said yesterday.

During this time, the vaccination campaign was below the usual average in a day in which less than a million doses were inoculated.

Since the start of this program last January, A total of 196 million doses of Covishield have been administered from AstraZeneca, which is manufactured by the Serum Institute of India (SII); Covaxin, from the Indian laboratory Bharat Biotech; and the Russian vaccine Sputnik V.

The drop may be due to the dose shortage reported by several states, forcing some like New Delhi to temporarily suspend the last phase of the vaccination process, which includes all adults between the ages of 18 and 44.

These figures are far from those set by the Indian authorities at the start of the program, in which they expected 300 million people to be vaccinated by July.

With information from EFE

KEEP READING: